検索結果

ntial cation channel subfamily V member 1 (TRPV1)*1 antagonist, designed to improve both subjective symptoms and objective signs of DED through inhibition of TRPV1. A pivotal Phase III clinical trial ...

Production | About Senju | SENJU Pharmaceutical

Trusted pharmaceutical products are created using the latest and best equipment in the environment with rich humanity. As ophthalmic solutions are required to meet the same quality standards as inject

Production | About Senju | SENJU Pharmaceutical

Trusted pharmaceutical products are created using the latest and best equipment in the environment with rich humanity. As ophthalmic solutions are required to meet the same quality standards as inject

ntial cation channel subfamily V member 1 (TRPV1)*1 antagonist, designed to improve both subjective symptoms and objective signs of DED through inhibition of TRPV1. A pivotal Phase III clinical trial ...

Compliance System | Our Initiatives for Society/Environment | About Senju | SENJU Pharmaceutical

nstantly alert, paying attention to views and voices within the company so as to uphold a corporate system and culture that are genuinely effective. In the event of any incident arising that goes agai...